GlaxoSmithKline PLC
| Year | Mar | Jun | Sep | Dec | Annual | |
|---|---|---|---|---|---|---|
| 2023 | 0.89 | 0.99 | 0.90 | - | - | |
| 2022 | - | - | - | 1.50 | - | |
| 2021 | 0.59 | 0.78 | 0.64 | 3.01 | 5.02 | |
| 2020 | 0.8 | 1.12 | 0.64 | 0.38 | 2.94 | |
| 2019 | 0.44 | 0.5 | 0.76 | 0.67 | 2.37 | |
| 2018 | 0.31 | 0.24 | 0.74 | 0.65 | 1.94 | |
| 2017 | 0.62 | 0.70 | 0.85 | 0.72 | 2.89 | |
| 2016 | 0.57 | 0.70 | 0.83 | 0.65 | 2.75 | |
| 2015 | 0.48 | 0.53 | 0.71 | 0.55 | 2.27 | |
| 2014 | 0.46 | 0.46 | 0.27 | 0.64 | 1.71 | |
| 2013 | 0.61 | 0.65 | 0.64 | 1.64 | 3.47 | |
| 2012 | 0.85 | 0.79 | 0.73 | 0.57 | 2.95 | |
| 2011 | 0.95 | 0.70 | 0.86 | 0.78 | 3.25 | |
| 2010 | 0.80 | -0.18 | 0.78 | -0.43 | 1.03 | |
| 2009 | 0.64 | 0.93 | 0.86 | 1.04 | 3.38 | |
| 2008 | 0.94 | 0.98 | 0.94 | 0.59 | 3.21 | |
| 2007 | 1.06 | 0.95 | 0.96 | 0.39 | 1.87 | |
| 2006 | 0.93 | 0.85 | 0.92 | 0.40 | 1.76 | |
| 2005 | 0.80 | 0.73 | 0.75 | 0.68 | 2.98 |